Literature DB >> 29961053

A Randomized Clinical Trial of Flex 19G Needles versus 22G Needles for Endobronchial Ultrasonography in Suspected Lung Cancer.

Christophe Dooms1, Sara Vander Borght2,3, Jonas Yserbyt1, Dries Testelmans1, Els Wauters1, Kristiaan Nackaerts1, Johan Vansteenkiste1, Eric Verbeken2, Birgit Weynand2.   

Abstract

BACKGROUND: A flexible 19-gauge (Flex 19G) needle has been developed for endobronchial ultrasonography.
OBJECTIVES: We aimed to evaluate quantitative and qualitative specimen characteristics of Flex 19G in a randomized controlled setting for patients with suspected lung cancer.
METHODS: We undertook a single-center, randomized, controlled trial. A computer-generated randomization assigned all enrolled patients 1: 1 to undergo endobronchial ultrasonography using a Flex 19G or a 22-gauge (22G) needle for lymph node tissue sampling. Pathologists were blinded to the group assignment. The primary end point was histological tissue core procurement. The secondary end points were diagnostic yield, specimen bloodiness and overall quality, tissue surface area and performance for next-generation sequencing (NGS), and procedure-related complications.
RESULTS: Between June 2016 and February 2017, we randomly allocated a total of 78 patients: 39 patients to Flex 19G and 39 patients to 22G. No superiority in tissue core procurement was observed for Flex 19G compared to 22G (67 vs. 72%, p = 0.81). No significant difference was observed in diagnostic yield and overall specimen quality, but transbronchial needle aspiration specimens by Flex 19G were bloodier and had a larger tissue surface area. NGS was successful for clinically relevant genes in 96% and for all 26 genes tested in 81% of the samples. There was no difference in clinically relevant complications.
CONCLUSIONS: No superiority is observed for Flex 19G in histological tissue core procurement rate. The Flex 19G needle could be considered when a larger tissue surface is of special interest.
© 2018 S. Karger AG, Basel.

Entities:  

Keywords:  EBUS-TBNA; Flexible 19G needles; Lung cancer; Lymph node; Next-generation sequencing; Randomized trial

Mesh:

Year:  2018        PMID: 29961053     DOI: 10.1159/000489473

Source DB:  PubMed          Journal:  Respiration        ISSN: 0025-7931            Impact factor:   3.580


  12 in total

1.  Prospective randomized trial to compare the safety, diagnostic yield and utility of 22-gauge and 19-gauge endobronchial ultrasound transbronchial needle aspirates and processing technique by cytology and histopathology.

Authors:  Christopher J Manley; Rohit Kumar; Yulan Gong; Min Huang; Shuanzeng Sam Wei; Rajeswari Nagarathinam; Alan Haber; Brian Egleston; Douglas Flieder; Hormoz Ehya
Journal:  J Am Soc Cytopathol       Date:  2021-10-23

2.  Efficacy and safety of ultrasound (US) guided percutaneous needle biopsy for peripheral lung or pleural lesion: comparison with computed tomography (CT) guided needle biopsy.

Authors:  Norio Yamamoto; Tetsuya Watanabe; Kazuhiro Yamada; Toshiyuki Nakai; Tomohiro Suzumura; Kazuki Sakagami; Naoki Yoshimoto; Kanako Sato; Hidenori Tanaka; Shigeki Mitsuoka; Kazuhisa Asai; Tatsuo Kimura; Hiroshi Kanazawa; Kazuto Hirata; Tomoya Kawaguchi
Journal:  J Thorac Dis       Date:  2019-03       Impact factor: 2.895

Review 3.  Linear Endobronchial Ultrasound in the Era of Personalized Lung Cancer Diagnostics-A Technical Review.

Authors:  Filiz Oezkan; Stephan Eisenmann; Kaid Darwiche; Asmae Gassa; David P Carbone; Robert E Merritt; Peter J Kneuertz
Journal:  J Clin Med       Date:  2021-11-30       Impact factor: 4.241

4.  Knowledge and Practice Patterns Among Pulmonologists for Molecular Biomarker Testing in Advanced Non-small Cell Lung Cancer.

Authors:  Adam H Fox; James R Jett; Upal Basu Roy; Bruce E Johnson; Jennifer C King; Nikki Martin; Raymond U Osarogiagbon; M Patricia Rivera; Lauren S Rosenthal; Robert A Smith; Gerard A Silvestri
Journal:  Chest       Date:  2021-06-26       Impact factor: 9.410

Review 5.  Bronchoscopic tissue yield for advanced molecular testing: are we getting enough?

Authors:  Pattraporn Tajarernmuang; Linda Ofiara; Stéphane Beaudoin; Anne V Gonzalez
Journal:  J Thorac Dis       Date:  2020-06       Impact factor: 3.005

Review 6.  Narrative review of tools for endoscopic ultrasound-guided biopsy of mediastinal nodes.

Authors:  Jenny Yang; Jose De Cardenas; Matthew Nobari; Russell Miller; George Cheng
Journal:  Mediastinum       Date:  2020-12-30

7.  Priority of PET-CT vs CT Thorax for EBUS-TBNA 22G vs 19G: Mesothorax Lymphadenopathy.

Authors:  Paul Zarogoulidis; Haidong Huang; Zhenli Hu; Ning Wu; Jiannan Wang; Dimitris Petridis; Kosmas Tsakiridis; Dimitris Matthaios; Christoforos Kosmidis; Wolfgang Hohenforst-Schmidt; Christos Tolis; Ioannis Boukovinas; Nikolaos Courcoutsakis; George Nikolaidis; Chrysanthi Sardeli; Chong Bai; Chrysanthi Karapantzou
Journal:  J Cancer       Date:  2021-08-05       Impact factor: 4.207

Review 8.  Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration (EBUS-TBNA): Technical Updates and Pathological Yield.

Authors:  Huzaifa A Jaliawala; Samid M Farooqui; Kassem Harris; Tony Abdo; Jean I Keddissi; Houssein A Youness
Journal:  Diagnostics (Basel)       Date:  2021-12-10

Review 9.  An evolving role for endobronchial ultrasonography in the intensive care unit.

Authors:  Or Kalchiem-Dekel; Saamia Hossain; Cosmin Gauran; Jason A Beattie; Bryan C Husta; Robert P Lee; Mohit Chawla
Journal:  J Thorac Dis       Date:  2021-08       Impact factor: 2.895

10.  Utilization of High-pressure Suction for EBUS-TBNA Sampling in Suspected Lung Cancer.

Authors:  George Tsaknis; Muhammad Naeem; Sridhar Rathinam; Alison Caswell; Jayne Haycock; Jane McKenna; Raja V Reddy
Journal:  J Bronchology Interv Pulmonol       Date:  2022-04-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.